Accuray radiotherapy dose calculation software:
This article was originally published in Clinica
Executive Summary
Accuray has received 510(k) clearance from the US FDA for its dose calculation software for radiotherapy. The technology - called the Monte Carlo Dose calculation algorithm - is now available for sale worldwide, reported the company. Traditional dose calculation methods assume all photons take a single path and therefore use a single calculation to represent the dose delivered by all photons. The Monte Carlo method, however, takes into account interactions of each individual photon when considering an appropriate dose. The Sunnyvale, California firm claims it will be the first company to market the technology. The product was launched at the 9th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain, during September 8-13.
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.